Select text to enable text to speech.

Publications

Mineralocorticoid receptor antagonism improves corneal integrity in a rat model of limbal stem cell deficiency

Rodrigues-Braz, D., Bonnet, C., Zhu, L., Yesilirmak, N., Gélizé, E., Jonet, L., Jaisser, F., Bourges, J.-L., Behar-Cohen, F., Zhao, M. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2025.117979

Comparison of in-vitro immunomodulatory capacity between large and small apoptotic bodies from human bone marrow mesenchymal stromal cells

Wang, J., Moosavizadeh, S., Jammes, M., Tabasi, A., Bach, T., Ryan, A. E., Ritter, T. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114480

Excipients in drug delivery systems: A comprehensive review of approved inactive ingredients for human ophthalmic formulations

Arribada, R. G., Rodrigues-Braz, D., Silva-Cunha, A., Behar-Cohen, F. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114637

Healing the cornea: Exploring the therapeutic solutions offered by MSCs and MSC-derived EVs

Jammes, M., Tabasi, A., Bach, T., Ritter, T. (2025). Progress in Retinal and Eye Research, 105, 101325. https://doi.org/10.1016/j.preteyeres.2024.101325

Selective, Temporary Postoperative Inhibition of Lymphangiogenesis by Integrin α5β1 Blockade Improves Allograft Survival in a Murine Model of High-Risk Corneal Transplantation.

Dietrich-Ntoukas T, Bock F, Onderka J, Hos D, Bachmann BO, Zahn G, Cursiefen C. J. Clin. Med. 2024; 13(15):4418. https://doi.org/10.3390/jcm13154418

Spironolactone Eyedrop Favors Restoration of Corneal Integrity after Wound Healing in the Rat

Rodrigues-Braz D, Zhu L, Gélizé E, Clarin J-P, Chatagnon X, Benzine Y, Rampignon P, Thouvenin A, Bourges J-L, Behar-Cohen F, et al. Spironolactone Eyedrop Favors Restoration of Corneal Integrity after Wound Healing in the Rat. Pharmaceuticals. 2023; 16(10):1446. https://doi.org/10.3390/ph16101446

Interested in Restore vision?

Stay informed about our efforts to combat rare eye diseases and bring new hope to those affected by visual impairment by subscribing to our newsletter for updates on our latest treatments and research.